Recent Company News

• 11:59 AM ET Mar 04, 2026
  

  Transcript Intelligence: Valneva at TD Cowen Health Care Conference

• 06:44 AM ET Feb 12, 2026
  

  StreetAccount Summary - European unusual volume traders

• 04:11 AM ET Feb 06, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:51 AM ET Feb 16, 2026
  

  StreetAccount Summary - European pre-market trading update

• 01:02 AM ET Feb 19, 2026
  

  Valneva reports prelim FY revenue €147.7M vs FactSet €169.1M [9 est, €150.3-179.8M]; guides FY26 (€4.63, 0.00)

• 11:52 AM ET Feb 13, 2026
  

  Valneva updates on recommendations for use of IXCHIQ in UK (€4.36, 0.00)

• 01:04 AM ET Feb 03, 2026
  

  Valneva announced the initiation of a Pilot Vaccination Strategy (PVS) in Brazil using Valneva's single-shot chikungunya vaccine IXCHIQ (€3.91, 0.00)